Seattle Flow Your front door to Seattle's startup scene.
Sign in
Stream Events Podcasts Videos Communities
Nate Bek / GeekWire

Seattle's Curevo Vaccine Appoints Guy De La Rosa as CMO to Challenge GSK's $2.3B Shingles Vaccine Market

Seattle vaccine developer Curevo Vaccine hired Guy De La Rosa as chief medical officer to advance its shingles vaccine targeting GSK's Shingrix. Additionally, notable hires include Christopher A. Klebanoff as Affini-T Therapeutics scientific co-founder and Buffy Alegria joining Loud Capital as managing partner.

  • Link
  • Report this item
Replying to

No comments yet.

Seattle Flow — Your front door to Seattle's startup scene.

Run by Marcelo Calbucci MC
Send us a link Terms of Service Privacy For AI assistants
© 2026 Seattle Flow. All rights reserved.

Who liked this

Edit history

Seattle Flow

Your front door to Seattle's startup scene.

Seattle's startup scene is scattered across a hundred feeds, newsletters, and calendars. Seattle Flow brings it together: the news, events, podcasts, and people, plus what the community is saying about them. Every link sends you to the source.

Writing about a Seattle founder, fund, or startup? We'll help it get seen. Found a great story we missed? Send it in.

We're in beta and building this with the community. Tell us what you want to see here.

Seattle's startup scene, every day. The news, events, podcasts, and people, plus what everyone's saying about them. We're in beta: send us a story or tell us what you want to see.